ID   397-mel/A31
AC   CVCL_A1DW
SY   397mel/A31
DR   cancercelllines; CVCL_A1DW
DR   Wikidata; Q102113441
RX   PubMed=9759882;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*31).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8050 ! 397-mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
RX   PubMed=9759882; DOI=10.4049/jimmunol.161.7.3596;
RA   Wang R.-F., Johnston S.L., Zeng G., Topalian S.L.,
RA   Schwartzentruber D.J., Rosenberg S.A.;
RT   "A breast and melanoma-shared tumor antigen: T cell responses to
RT   antigenic peptides translated from different open reading frames.";
RL   J. Immunol. 161:3596-3606(1998).
//